This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

5 Most Undervalued Stocks in the S&P 500

By Ryan Fuhrmann

NEW YORK ( TheStreet ) -- Wal-Mart (WMT - Get Report), Abbott Labs (ABT - Get Report), Kimberly-Clark (KMB - Get Report), Coca-Cola (KO - Get Report) and Eli Lilly (LLY - Get Report) are five companies in the S&P 500 with the best dividend growth and earnings prospects.

Dividend-paying stocks are appealing because they have a track record of beating the broader stock market. Focusing on the most undervalued names of the S&P's so-called dividend aristocrats means investing in the most undervalued companies.

>>Also: 21 S&P 500 Stocks Up More Than 40%

The companies mentioned here also offer downside protection, given their products can be considered recession-resistant. For those particularly inclined to high dividend payments, Kimberly-Clark and Eli Lilly stand out from the rest.

Wal-Mart (WMT)

Business: World's Largest Retailer

Current P/E ratio: 13.9

Current dividend yield: 2.3%

I recently concluded that Wal-Mart is the one blue-chip that every investor should own, which stems from the fact that it is one of the safest investments out there (Read The One Blue-Chip Stock Every Investor Should Own). First, it is using its impressive profit generation in the United States to fund overseas growth. This strategy has allowed sales to grow at least +10% annually during the past decade.

Sales should grow in the high single digits going forward, but cost containment and other productivity enhancements should push profits up in the double digits each year going forward. Wal-Mart is also an ideal pick for investors worried about a double-dip recession or a failure of the global economy to recover fully from the credit crisis. Given its additional focus on dividends and ability to boost the payout over time, this stock pick is hard to argue against.

Abbott Labs (ABT)

Business: Pharmaceuticals

Current P/E ratio: 15.5

Current Dividend Yield: 3.3%

Abbott is a healthcare bellwether and has a globally diversified business across a number of different product categories. In addition to pharmaceutical sales, it sells medical devices and consumer products, such as Similac baby formula. Abbot's sights are also set overseas, and it recently announced a deal that will make it one of the largest healthcare firms in India. A low P/E, high and rising dividend yield, and double-digit growth prospects over the long haul make this an undervalued stock at current prices.


Business: Consumer Goods

Current P/E ratio: 14.0

Current Dividend Yield: 4.1%

Kimberly-Clark used to qualify as a stodgy consumer goods firm, but has become religious on controlling costs. In the past three years, it has been able to leverage modest sales growth of under 4% per year into double-digit earnings increases that have averaged nearly 12% annually. A 4.1% dividend yield also makes it one of the most generous payers out of all the dividend aristocrats. Dividend stability and improved profit growth mean Kimberly-Clark also stands out as one of the most undervalued names in the S&P 500.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
ABT $37.00 -1.23%
KMB $130.79 1.05%
KO $43.30 1.52%
LLY $73.74 -0.61%
WMT $65.81 -1.63%


Chart of I:DJI
DOW 16,014.38 -12.67 -0.08%
S&P 500 1,852.21 -1.23 -0.07%
NASDAQ 4,268.7630 -14.99 -0.35%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs